This content is machine translated Practice Changing The most important studies at a glance As usual, at this year’s Congress of the European Society for Medical Oncology (ESMO), those studies with the greatest impact on daily practice were presented in three so-called Presidential Symposia. We…
View Post 4 min This content is machine translated Gastroenterological endoscopy Colorectal cancer screening during and after the corona pandemic Screening colonoscopies are associated with great health benefits. This has been scientifically proven. If intestinal polyps are detected and removed in time, the risk of a malignant intestinal tumor can…
View Post 14 min This content is machine translated Gastrointestinal carcinomas New therapy options in 2021 Malignant tumors of the gastrointestinal tract are common, and the need for additional therapeutic options is high. At this year’s ASCO Annual Meeting, exciting new study results were presented for… CME-Test
View Post 8 min This content is machine translated Advanced breast carcinoma What’s new? With antibody-drug conjugates, checkpoint and CDK4/6 inhibitors, three drug classes were in the spotlight at this year’s European Society for Medical Oncology (ESMO) congress in advanced breast cancer. This is…
View Post 3 min This content is machine translated Telemedicine in integrative oncology Improve quality of life Ensuring quality of care for oncology patients is a major challenge in light of the COVID 19 pandemic. In particular, non-essential therapies, which can be of great importance for the…
View Post 3 min This content is machine translated The somewhat different knowledge What is actually… Peto’s paradox? Or: Why don’t all blue whales have cancer? Like elephants, these giant, long-lived mammals are not affected by malignancies more often than other species. Strange actually, considering the long life…
View Post 10 min This content is machine translated Advanced urothelial carcinoma of the urinary bladder Systemic therapy With approximately 1150 new cases annually in Switzerland, urothelial carcinoma of the urinary bladder is one of the most common cancers of older age. Particularly in the metastatic setting, it… CME-Test
View Post 4 min This content is machine translated Acute myeloid leukemia (AML) “A new standard of care for elderly and fragile patients” A BCL-2 inhibitor is convincing in new studies in the first-line treatment of AML patients who are not suitable for intensive chemotherapy [1]. Hematologists Dr. Georgios Georgiou and Prof. Photis…
View Post 7 min This content is machine translated TRK Inhibitors Entity-independent cancer therapy: a glimpse of the future? Since 2020, two TRK inhibitors have been approved in Switzerland for tumor diagnosis, i.e. independent of tumor entity. They are designed to treat any solid tumor with NTRK gene fusions,…
View Post 4 min This content is machine translated Non-small cell lung cancer The role of adjuvant EGFR TKIs. Over the past several years, tyrosine kinase inhibitors directed against EGFR have gained acceptance as first-line treatment for advanced NSCLC with EGFR mutation. However, their role in adjuvant therapy of…
View Post 7 min This content is machine translated Renal cell carcinoma The most important studies at a glance Some exciting studies were presented on renal cell carcinoma at this year’s ASCO annual meeting. Especially for localized tumors, clinical practice may change in the near future. For the first…
